Hot news and topical articles.
Acomplia: A Magical Tool to Fight Obesity
Obesity is a very dangerous monster in these days all around the world much people are suffering from this. As monster can be defeated by the right weapons the same for obesity. The first thing to keep in mind before fight to obesity is fully information about this evil or obesity.
Obesity can be implicit as a dietary disorder, which can be measured by the means of BMI. The reason behind this obesity is a lot of but mainly we count like genetical disorder and imbalanced diet with unsuitable physical work. Now question arise in mind is there an effectual treatment for obesity? Definitely, Diet pills are an answer to this question. There are many diet pills in the market to fight obesity like Xenical, Acomplia, Phentermine and Adipex.
Acomplia diet pill can offer you a solution to your weight loss problem in an effective manner. Actually Acomplia works by obstructing the CB-1 receptors, which are responsible for food intake in the body. Even analysts believe that Acomplia could be the next the next multibillion dollar weight loss pill. According to the initial reports, Acomplia has been received very well in Europe. The company claims that Acomplia diet pill not only help in weight loss but could also useful in controlling blood sugar levels in individuals with type-2 diabetes patients.
Acomplia diet pill can offer you a solution to your weight loss problem in an effectual manner. Some doctors have hailed Acomplia on the basis of clinical trials as a major break through in the treatment of obesity. Acomplia is a selective CB1 endocannabinoid receptor and works by blocking the CB1 receptor, one of the two receptors found in a newly described physiological system called the Endocannabinoid System (EC system) believed to play a critical role in the regulation of food intake and energy expenditure.
Most of the experts feel that Acomplia is the answer to the long term treatment of obesity. Even though Acomplia awaits approval in the US and many question the effectiveness of the drug, Acomplia has many supporters. According to some experts many people believe that the cause for obesity is lack of will power to stop eating could actually have a biochemical basis found in the endocannabinoid system. Experts says that when you eat a high-fat, high-carbohydrate food, it activates the endocannabinoid system, leading you to eat even more.
As Acomplia is in waiting of approval by FDA (Food and Drug Administration) as most expert believe that the FDA is not too convinced about Acomplia’s dual benefits. Some cardiologists, who are excited about the drug because of its possible to reduce the risk of heart disease, are also worried about Acomplia’s side effects. Psychiatric symptoms of anxiety are one of the most common reasons patients stopped taking Acomplia in clinical trials. It is the pill that blocks the happy receptor. The main reason for concern is that it might have a bad impact on depression or suicide.
In a study obese women wre found to have higher levels of endocannabinoids than lean women. Blocking cannabinoid receptors dampen an overactive EC system, reining in appetite. After being hailed as a wonder drug, Acomplia since its launch in Europe has reported adverse side effects. There have been dozens of cases which have reported cases of psychiatric disorders in patients who have been using Acomplia. Acomplia has no long term studies to prove that there could be side effects related to the brain. The company claims that these side effects are minor ones. The US FDA is still studying the side effects before it says yes to Acomplia.
|